

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.09314439 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.09314439 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.97255618 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.97255618 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.34491668 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.19333791 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.78931076 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.78931076 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.78931076 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.62048374 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.56026192 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.53422246 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.49637177 |
| 14 | cysteine metabolic process (GO:0006534) | 5.43860609 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 5.23894060 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.23141722 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.15007856 |
| 18 | serine family amino acid catabolic process (GO:0009071) | 5.08986364 |
| 19 | response to peptidoglycan (GO:0032494) | 5.05108018 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.04411293 |
| 21 | urea cycle (GO:0000050) | 5.02478791 |
| 22 | urea metabolic process (GO:0019627) | 5.02478791 |
| 23 | regulation of fibrinolysis (GO:0051917) | 4.97911843 |
| 24 | glycine metabolic process (GO:0006544) | 4.89648860 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 4.89085329 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 4.89085329 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.89085329 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.89085329 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.89085329 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 4.89085329 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.85990080 |
| 32 | protein carboxylation (GO:0018214) | 4.85990080 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 4.80299877 |
| 34 | regulation of protein activation cascade (GO:2000257) | 4.79237384 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.77510594 |
| 36 | neutrophil activation involved in immune response (GO:0002283) | 4.71975527 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.71796520 |
| 38 | negative regulation of interleukin-12 production (GO:0032695) | 4.69531461 |
| 39 | bile acid metabolic process (GO:0008206) | 4.67551750 |
| 40 | detection of bacterium (GO:0016045) | 4.67452887 |
| 41 | nitrogen cycle metabolic process (GO:0071941) | 4.65370864 |
| 42 | detection of other organism (GO:0098543) | 4.62811594 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.62421742 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.58068667 |
| 45 | complement activation, alternative pathway (GO:0006957) | 4.57087502 |
| 46 | serine family amino acid biosynthetic process (GO:0009070) | 4.50916766 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 4.46335676 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.46335676 |
| 49 | regulation of complement activation (GO:0030449) | 4.45777470 |
| 50 | reverse cholesterol transport (GO:0043691) | 4.44794525 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 4.44396712 |
| 52 | serine family amino acid metabolic process (GO:0009069) | 4.43701539 |
| 53 | phospholipid efflux (GO:0033700) | 4.43054310 |
| 54 | coenzyme catabolic process (GO:0009109) | 4.42864086 |
| 55 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.42419412 |
| 56 | protein-lipid complex remodeling (GO:0034368) | 4.42398434 |
| 57 | macromolecular complex remodeling (GO:0034367) | 4.42398434 |
| 58 | plasma lipoprotein particle remodeling (GO:0034369) | 4.42398434 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 4.38434667 |
| 60 | tyrosine metabolic process (GO:0006570) | 4.37608356 |
| 61 | alpha-amino acid catabolic process (GO:1901606) | 4.35501099 |
| 62 | imidazole-containing compound metabolic process (GO:0052803) | 4.35176863 |
| 63 | acylglycerol homeostasis (GO:0055090) | 4.35128600 |
| 64 | triglyceride homeostasis (GO:0070328) | 4.35128600 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 4.34087761 |
| 66 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.32271925 |
| 67 | negative regulation of cell killing (GO:0031342) | 4.32271925 |
| 68 | type I interferon signaling pathway (GO:0060337) | 4.30090896 |
| 69 | cellular response to type I interferon (GO:0071357) | 4.30090896 |
| 70 | response to type I interferon (GO:0034340) | 4.24717235 |
| 71 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.15254850 |
| 72 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.14880393 |
| 73 | lysine metabolic process (GO:0006553) | 4.14748584 |
| 74 | lysine catabolic process (GO:0006554) | 4.14748584 |
| 75 | homocysteine metabolic process (GO:0050667) | 4.14073041 |
| 76 | indolalkylamine metabolic process (GO:0006586) | 4.13382388 |
| 77 | aldehyde catabolic process (GO:0046185) | 4.10637599 |
| 78 | bile acid and bile salt transport (GO:0015721) | 4.10317132 |
| 79 | cellular amino acid catabolic process (GO:0009063) | 4.02402744 |
| 80 | amine catabolic process (GO:0009310) | 4.00999286 |
| 81 | cellular biogenic amine catabolic process (GO:0042402) | 4.00999286 |
| 82 | ethanol oxidation (GO:0006069) | 3.99556153 |
| 83 | NIK/NF-kappaB signaling (GO:0038061) | 3.97514881 |
| 84 | blood coagulation, intrinsic pathway (GO:0007597) | 3.97104466 |
| 85 | plasma lipoprotein particle clearance (GO:0034381) | 3.95029657 |
| 86 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.93059398 |
| 87 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.90282208 |
| 88 | detection of external biotic stimulus (GO:0098581) | 3.85935063 |
| 89 | cofactor catabolic process (GO:0051187) | 3.84559857 |
| 90 | glutamate metabolic process (GO:0006536) | 3.84116393 |
| 91 | cellular glucuronidation (GO:0052695) | 3.82233108 |
| 92 | arginine metabolic process (GO:0006525) | 3.80037786 |
| 93 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.79210194 |
| 94 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.79210194 |
| 95 | cellular modified amino acid catabolic process (GO:0042219) | 3.79097057 |
| 96 | L-serine metabolic process (GO:0006563) | 3.78127838 |
| 97 | cholesterol efflux (GO:0033344) | 3.76978666 |
| 98 | benzene-containing compound metabolic process (GO:0042537) | 3.75925758 |
| 99 | plasma lipoprotein particle assembly (GO:0034377) | 3.75694371 |
| 100 | ketone body metabolic process (GO:1902224) | 3.75045845 |
| 101 | low-density lipoprotein particle remodeling (GO:0034374) | 3.72827013 |
| 102 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.71749640 |
| 103 | NAD biosynthetic process (GO:0009435) | 3.68168615 |
| 104 | B cell mediated immunity (GO:0019724) | 3.65925848 |
| 105 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.62910727 |
| 106 | fibrinolysis (GO:0042730) | 3.61264013 |
| 107 | carboxylic acid catabolic process (GO:0046395) | 3.55371071 |
| 108 | organic acid catabolic process (GO:0016054) | 3.55371071 |
| 109 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.54259417 |
| 110 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.54259417 |
| 111 | opsonization (GO:0008228) | 3.53560257 |
| 112 | complement activation, classical pathway (GO:0006958) | 3.53043525 |
| 113 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.51705731 |
| 114 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.47409845 |
| 115 | protein activation cascade (GO:0072376) | 3.45529388 |
| 116 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.43982628 |
| 117 | response to nitrosative stress (GO:0051409) | 3.42949312 |
| 118 | detection of biotic stimulus (GO:0009595) | 3.42749382 |
| 119 | response to interferon-beta (GO:0035456) | 3.40561247 |
| 120 | detection of molecule of bacterial origin (GO:0032490) | 3.39680523 |
| 121 | complement activation (GO:0006956) | 3.39486555 |
| 122 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.36606855 |
| 123 | cholesterol homeostasis (GO:0042632) | 3.35639534 |
| 124 | glucuronate metabolic process (GO:0019585) | 3.33793859 |
| 125 | uronic acid metabolic process (GO:0006063) | 3.33793859 |
| 126 | response to host immune response (GO:0052572) | 3.32030842 |
| 127 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.32030842 |
| 128 | cytolysis (GO:0019835) | 3.31305534 |
| 129 | one-carbon metabolic process (GO:0006730) | 3.31027370 |
| 130 | leukocyte aggregation (GO:0070486) | 3.30541352 |
| 131 | respiratory burst (GO:0045730) | 3.30320073 |
| 132 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.30114724 |
| 133 | regulation of mast cell degranulation (GO:0043304) | 3.30077819 |
| 134 | plasma lipoprotein particle organization (GO:0071827) | 3.29607103 |
| 135 | negative regulation of lipase activity (GO:0060192) | 3.28686379 |
| 136 | flavonoid metabolic process (GO:0009812) | 3.28605371 |
| 137 | sterol homeostasis (GO:0055092) | 3.28571465 |
| 138 | protein-lipid complex assembly (GO:0065005) | 3.28310641 |
| 139 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.25523532 |
| 140 | positive regulation of antigen processing and presentation (GO:0002579) | 3.24397201 |
| 141 | myeloid cell activation involved in immune response (GO:0002275) | 3.21714784 |
| 142 | pyrimidine nucleoside salvage (GO:0043097) | 3.19460564 |
| 143 | pyrimidine-containing compound salvage (GO:0008655) | 3.19460564 |
| 144 | negative regulation of innate immune response (GO:0045824) | 3.17897953 |
| 145 | regulation of antigen processing and presentation (GO:0002577) | 3.17439624 |
| 146 | defense response to protozoan (GO:0042832) | 3.16725078 |
| 147 | myeloid dendritic cell differentiation (GO:0043011) | 3.13621773 |
| 148 | germinal center formation (GO:0002467) | 3.11589409 |
| 149 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.10751448 |
| 150 | granulocyte activation (GO:0036230) | 3.08335273 |
| 151 | response to protozoan (GO:0001562) | 3.05615577 |
| 152 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04171797 |
| 153 | response to muramyl dipeptide (GO:0032495) | 3.03359240 |
| 154 | myeloid dendritic cell activation (GO:0001773) | 3.00891274 |
| 155 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.99535262 |
| 156 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.99304697 |
| 157 | response to host (GO:0075136) | 2.99304697 |
| 158 | response to host defenses (GO:0052200) | 2.99304697 |
| 159 | macrophage activation (GO:0042116) | 2.98904802 |
| 160 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.97212390 |
| 161 | positive regulation of type 2 immune response (GO:0002830) | 2.96774609 |
| 162 | neutrophil activation (GO:0042119) | 2.94792628 |
| 163 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.94598572 |
| 164 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.94028661 |
| 165 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.92324262 |
| 166 | regulation of interferon-alpha production (GO:0032647) | 2.91404500 |
| 167 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.89940316 |
| 168 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.87916862 |
| 169 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.87666600 |
| 170 | T-helper 1 type immune response (GO:0042088) | 2.87077282 |
| 171 | response to interferon-alpha (GO:0035455) | 2.86532852 |
| 172 | positive regulation of interferon-alpha production (GO:0032727) | 2.86503740 |
| 173 | cellular response to interferon-gamma (GO:0071346) | 2.85965665 |
| 174 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.84368137 |
| 175 | regulation of T cell tolerance induction (GO:0002664) | 2.82949020 |
| 176 | regulation of leukocyte degranulation (GO:0043300) | 2.82654397 |
| 177 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.79808650 |
| 178 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.77146891 |
| 179 | positive regulation of mast cell activation (GO:0033005) | 2.76975989 |
| 180 | response to interferon-gamma (GO:0034341) | 2.76710201 |
| 181 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.75440001 |
| 182 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.74101901 |
| 183 | regulation of tolerance induction (GO:0002643) | 2.72029753 |
| 184 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.71595408 |
| 185 | microglial cell activation (GO:0001774) | 2.70512828 |
| 186 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.70034769 |
| 187 | regulation of gamma-delta T cell activation (GO:0046643) | 2.64848351 |
| 188 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.64568150 |
| 189 | amino sugar catabolic process (GO:0046348) | 2.63918100 |
| 190 | positive regulation of mast cell degranulation (GO:0043306) | 2.61711057 |
| 191 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.61711057 |
| 192 | regulation of mast cell activation (GO:0033003) | 2.58367580 |
| 193 | negative regulation of viral genome replication (GO:0045071) | 2.56861771 |
| 194 | regulation of type 2 immune response (GO:0002828) | 2.56004499 |
| 195 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.54013543 |
| 196 | regulation of superoxide anion generation (GO:0032928) | 2.53626631 |
| 197 | negative regulation of T cell mediated immunity (GO:0002710) | 2.52048642 |
| 198 | cellular response to interferon-beta (GO:0035458) | 2.50904724 |
| 199 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.49931548 |
| 200 | positive regulation of interferon-beta production (GO:0032728) | 2.48609662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.00662714 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.11957113 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.98192636 |
| 4 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.99867858 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.94194903 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.63468542 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.23427443 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.03545373 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.16688224 |
| 10 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.16376673 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.99603713 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.63081969 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.41352794 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.39670166 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.19475209 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.16000882 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.12850671 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08056517 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.06029375 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1712511 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 1.97893358 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97881390 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.96420681 |
| 24 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.92498604 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.90739831 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90693617 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.89318783 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86059231 |
| 29 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.85182472 |
| 30 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.85005453 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.84561806 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75872683 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74815890 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66352070 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65670257 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65216790 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.64710506 |
| 38 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.64333477 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63871638 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60498985 |
| 41 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.59009871 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57878352 |
| 43 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.57122168 |
| 44 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.56088778 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.53988509 |
| 46 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.50833504 |
| 47 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.49127808 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49044568 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48338818 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.47121386 |
| 51 | P68_20966046_ChIP-Seq_HELA_Human | 1.46347211 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.45394727 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44212865 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.42968685 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42265508 |
| 56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42056164 |
| 57 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.40194479 |
| 58 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.39920833 |
| 59 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.36362617 |
| 60 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.34933368 |
| 61 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.34756635 |
| 62 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34492548 |
| 63 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.33208036 |
| 64 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.32684342 |
| 65 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31659356 |
| 66 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30595493 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29330549 |
| 68 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.25961457 |
| 69 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.23883954 |
| 70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23721480 |
| 71 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.21510003 |
| 72 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21109483 |
| 73 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.20975185 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19327332 |
| 75 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18201552 |
| 76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.18064707 |
| 77 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.17803897 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12725376 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12450466 |
| 80 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11686920 |
| 81 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.10440637 |
| 82 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10432317 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09954971 |
| 84 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09886663 |
| 85 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.09611226 |
| 86 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.09009241 |
| 87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08680396 |
| 88 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.07989383 |
| 89 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.07988922 |
| 90 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06683345 |
| 91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06014148 |
| 92 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.05360209 |
| 93 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05022381 |
| 94 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04561108 |
| 95 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04518503 |
| 96 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04452889 |
| 97 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.04163404 |
| 98 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03620157 |
| 99 | MYB_26560356_Chip-Seq_TH2_Human | 1.03410680 |
| 100 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02866688 |
| 101 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02225858 |
| 102 | MYB_26560356_Chip-Seq_TH1_Human | 1.01124899 |
| 103 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.00676233 |
| 104 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00597370 |
| 105 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00351403 |
| 106 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.99872479 |
| 107 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99487252 |
| 108 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.97951995 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97582495 |
| 110 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97318104 |
| 111 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97299700 |
| 112 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.97154724 |
| 113 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96948893 |
| 114 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95211438 |
| 115 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.94087896 |
| 116 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.92867715 |
| 117 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91758032 |
| 118 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.89377101 |
| 119 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.87470686 |
| 120 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.87005710 |
| 121 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.84794309 |
| 122 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.84757883 |
| 123 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.84555736 |
| 124 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.84101916 |
| 125 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83848079 |
| 126 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.83802898 |
| 127 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.81880458 |
| 128 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.81320979 |
| 129 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81142047 |
| 130 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.79266791 |
| 131 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.78087168 |
| 132 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76487770 |
| 133 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.76300595 |
| 134 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76263241 |
| 135 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.75288883 |
| 136 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.73679579 |
| 137 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.71873896 |
| 138 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71672145 |
| 139 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.70871227 |
| 140 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.70623922 |
| 141 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.69821563 |
| 142 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68841055 |
| 143 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.68341234 |
| 144 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.67234914 |
| 145 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.65991675 |
| 146 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.65460781 |
| 147 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.64540838 |
| 148 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.64464599 |
| 149 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.64329699 |
| 150 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.64294735 |
| 151 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.64187861 |
| 152 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.62526663 |
| 153 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.62315481 |
| 154 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61574403 |
| 155 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.61230918 |
| 156 | AR_20517297_ChIP-Seq_VCAP_Human | 0.60848502 |
| 157 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.60561773 |
| 158 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.59871740 |
| 159 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.58157797 |
| 160 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.57825897 |
| 161 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.57688364 |
| 162 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.57625934 |
| 163 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.57195988 |
| 164 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.57131644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.04851426 |
| 2 | MP0005360_urolithiasis | 6.94998694 |
| 3 | MP0005365_abnormal_bile_salt | 5.98934091 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.96893009 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 5.13968401 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.77836865 |
| 7 | MP0003303_peritoneal_inflammation | 4.04434603 |
| 8 | MP0009840_abnormal_foam_cell | 3.90593825 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.48164314 |
| 10 | MP0003252_abnormal_bile_duct | 3.47152711 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.45015006 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.80974568 |
| 13 | MP0005083_abnormal_biliary_tract | 2.79420097 |
| 14 | MP0005387_immune_system_phenotype | 2.75284994 |
| 15 | MP0001790_abnormal_immune_system | 2.75284994 |
| 16 | MP0005332_abnormal_amino_acid | 2.67237155 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.65080583 |
| 18 | MP0003195_calcinosis | 2.61364079 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.57839411 |
| 20 | MP0005671_abnormal_response_to | 2.56366402 |
| 21 | MP0008260_abnormal_autophagy | 2.45625086 |
| 22 | MP0001800_abnormal_humoral_immune | 2.41135624 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.39667782 |
| 24 | MP0002723_abnormal_immune_serum | 2.32496684 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.29655730 |
| 26 | MP0004510_myositis | 2.15763221 |
| 27 | * MP0000609_abnormal_liver_physiology | 2.10698310 |
| 28 | MP0001819_abnormal_immune_cell | 2.10479551 |
| 29 | MP0002420_abnormal_adaptive_immunity | 2.10280531 |
| 30 | MP0005451_abnormal_body_composition | 2.02035324 |
| 31 | MP0002118_abnormal_lipid_homeostasis | 1.95310243 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.93380244 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.91276971 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.91167239 |
| 35 | MP0009278_abnormal_bone_marrow | 1.85956787 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.85816905 |
| 37 | MP0001764_abnormal_homeostasis | 1.85062757 |
| 38 | MP0009697_abnormal_copulation | 1.84025307 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.82081429 |
| 40 | MP0003186_abnormal_redox_activity | 1.72875233 |
| 41 | MP0003868_abnormal_feces_composition | 1.69073481 |
| 42 | MP0000858_altered_metastatic_potential | 1.68724276 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.68529293 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.68437547 |
| 45 | MP0004947_skin_inflammation | 1.68334078 |
| 46 | MP0000343_altered_response_to | 1.67638613 |
| 47 | MP0002405_respiratory_system_inflammati | 1.63895579 |
| 48 | MP0000716_abnormal_immune_system | 1.57344281 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.56223614 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.49770586 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.46919799 |
| 52 | MP0002398_abnormal_bone_marrow | 1.44318159 |
| 53 | MP0003011_delayed_dark_adaptation | 1.43303870 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.41776100 |
| 55 | MP0005310_abnormal_salivary_gland | 1.40603646 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.39731171 |
| 57 | MP0003763_abnormal_thymus_physiology | 1.39284206 |
| 58 | MP0002429_abnormal_blood_cell | 1.30812697 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.30264104 |
| 60 | MP0000598_abnormal_liver_morphology | 1.22823926 |
| 61 | MP0003448_altered_tumor_morphology | 1.19561660 |
| 62 | MP0002722_abnormal_immune_system | 1.18612486 |
| 63 | MP0000689_abnormal_spleen_morphology | 1.18557123 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 1.18139369 |
| 65 | MP0009643_abnormal_urine_homeostasis | 1.17745992 |
| 66 | MP0001873_stomach_inflammation | 1.16551159 |
| 67 | MP0008004_abnormal_stomach_pH | 1.15161954 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 1.12750221 |
| 69 | MP0008469_abnormal_protein_level | 1.09941952 |
| 70 | MP0010368_abnormal_lymphatic_system | 1.09839462 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.08892407 |
| 72 | MP0009764_decreased_sensitivity_to | 1.07207160 |
| 73 | MP0005647_abnormal_sex_gland | 1.06527917 |
| 74 | MP0009763_increased_sensitivity_to | 1.03531662 |
| 75 | MP0003866_abnormal_defecation | 1.02605673 |
| 76 | MP0003828_pulmonary_edema | 1.01950103 |
| 77 | MP0000604_amyloidosis | 0.99013943 |
| 78 | * MP0005636_abnormal_mineral_homeostasis | 0.98565244 |
| 79 | MP0000490_abnormal_crypts_of | 0.95448286 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 0.94126952 |
| 81 | MP0009642_abnormal_blood_homeostasis | 0.92333303 |
| 82 | * MP0005376_homeostasis/metabolism_phenot | 0.92286330 |
| 83 | MP0009379_abnormal_foot_pigmentation | 0.89321281 |
| 84 | MP0001663_abnormal_digestive_system | 0.88963215 |
| 85 | MP0003718_maternal_effect | 0.84745047 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.83398674 |
| 87 | MP0002254_reproductive_system_inflammat | 0.82728061 |
| 88 | MP0002132_abnormal_respiratory_system | 0.82286982 |
| 89 | * MP0005266_abnormal_metabolism | 0.82064931 |
| 90 | MP0005390_skeleton_phenotype | 0.81810973 |
| 91 | MP0000703_abnormal_thymus_morphology | 0.81032881 |
| 92 | MP0003436_decreased_susceptibility_to | 0.79812883 |
| 93 | MP0001853_heart_inflammation | 0.77355181 |
| 94 | MP0005220_abnormal_exocrine_pancreas | 0.76763256 |
| 95 | MP0005464_abnormal_platelet_physiology | 0.76286531 |
| 96 | MP0005408_hypopigmentation | 0.74945421 |
| 97 | MP0003724_increased_susceptibility_to | 0.74590329 |
| 98 | MP0001851_eye_inflammation | 0.73240074 |
| 99 | MP0006082_CNS_inflammation | 0.71999545 |
| 100 | MP0004147_increased_porphyrin_level | 0.66954721 |
| 101 | MP0005075_abnormal_melanosome_morpholog | 0.66685117 |
| 102 | MP0002078_abnormal_glucose_homeostasis | 0.66143310 |
| 103 | MP0002796_impaired_skin_barrier | 0.63598890 |
| 104 | MP0004858_abnormal_nervous_system | 0.62642858 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.62554161 |
| 106 | MP0005165_increased_susceptibility_to | 0.61682698 |
| 107 | MP0005334_abnormal_fat_pad | 0.60931623 |
| 108 | MP0004381_abnormal_hair_follicle | 0.60684652 |
| 109 | MP0003690_abnormal_glial_cell | 0.60021147 |
| 110 | MP0002933_joint_inflammation | 0.58258343 |
| 111 | MP0009785_altered_susceptibility_to | 0.57559441 |
| 112 | MP0008873_increased_physiological_sensi | 0.57376601 |
| 113 | MP0003795_abnormal_bone_structure | 0.56395810 |
| 114 | MP0004883_abnormal_blood_vessel | 0.55677189 |
| 115 | MP0002971_abnormal_brown_adipose | 0.55069043 |
| 116 | MP0003705_abnormal_hypodermis_morpholog | 0.54917889 |
| 117 | MP0001661_extended_life_span | 0.54085510 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.53948385 |
| 119 | MP0005448_abnormal_energy_balance | 0.53936174 |
| 120 | MP0000639_abnormal_adrenal_gland | 0.53882427 |
| 121 | MP0002653_abnormal_ependyma_morphology | 0.53343209 |
| 122 | MP0000678_abnormal_parathyroid_gland | 0.52734951 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.52728557 |
| 124 | MP0009931_abnormal_skin_appearance | 0.52002313 |
| 125 | MP0005381_digestive/alimentary_phenotyp | 0.51713537 |
| 126 | MP0002019_abnormal_tumor_incidence | 0.51629009 |
| 127 | MP0005535_abnormal_body_temperature | 0.51080868 |
| 128 | MP0003329_amyloid_beta_deposits | 0.50821204 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.50374266 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.47660407 |
| 131 | MP0001756_abnormal_urination | 0.46476933 |
| 132 | MP0005025_abnormal_response_to | 0.42435471 |
| 133 | MP0005058_abnormal_lysosome_morphology | 0.40827983 |
| 134 | MP0000685_abnormal_immune_system | 0.40414953 |
| 135 | MP0004782_abnormal_surfactant_physiolog | 0.39936733 |
| 136 | MP0002136_abnormal_kidney_physiology | 0.39396313 |
| 137 | MP0005395_other_phenotype | 0.39021601 |
| 138 | MP0002970_abnormal_white_adipose | 0.38769621 |
| 139 | MP0003953_abnormal_hormone_level | 0.37278942 |
| 140 | MP0005166_decreased_susceptibility_to | 0.36053919 |
| 141 | MP0005397_hematopoietic_system_phenotyp | 0.35657973 |
| 142 | MP0001545_abnormal_hematopoietic_system | 0.35657973 |
| 143 | MP0008872_abnormal_physiological_respon | 0.34935529 |
| 144 | MP0000358_abnormal_cell_content/ | 0.34354656 |
| 145 | MP0008874_decreased_physiological_sensi | 0.34281714 |
| 146 | MP0002822_catalepsy | 0.33244656 |
| 147 | MP0009384_cardiac_valve_regurgitation | 0.31238954 |
| 148 | MP0000249_abnormal_blood_vessel | 0.30833548 |
| 149 | MP0004130_abnormal_muscle_cell | 0.29218609 |
| 150 | MP0003075_altered_response_to | 0.29174041 |
| 151 | MP0000230_abnormal_systemic_arterial | 0.29120751 |
| 152 | MP0005670_abnormal_white_adipose | 0.28667699 |
| 153 | MP0002419_abnormal_innate_immunity | 0.28018020 |
| 154 | MP0009672_abnormal_birth_weight | 0.27189907 |
| 155 | MP0009053_abnormal_anal_canal | 0.26133442 |
| 156 | MP0001542_abnormal_bone_strength | 0.26126994 |
| 157 | MP0009333_abnormal_splenocyte_physiolog | 0.25763891 |
| 158 | MP0009115_abnormal_fat_cell | 0.25260439 |
| 159 | MP0005164_abnormal_response_to | 0.24481137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.14765026 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 6.48514802 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.48288754 |
| 4 | Deep venous thrombosis (HP:0002625) | 6.18785168 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.03123013 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.00104269 |
| 7 | Xanthomatosis (HP:0000991) | 5.65871109 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.37837307 |
| 9 | Abnormality of macrophages (HP:0004311) | 5.08998475 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.98623073 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.93680274 |
| 12 | Eczematoid dermatitis (HP:0000976) | 4.90314792 |
| 13 | Hyperglycinemia (HP:0002154) | 4.54766713 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.48981723 |
| 15 | Hyperammonemia (HP:0001987) | 4.37760623 |
| 16 | Complement deficiency (HP:0004431) | 4.34475780 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.23571139 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.23571139 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 4.23571139 |
| 20 | Myositis (HP:0100614) | 4.18538599 |
| 21 | Joint hemorrhage (HP:0005261) | 4.15005838 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.05582505 |
| 23 | Hyperglycinuria (HP:0003108) | 4.00292069 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.00265133 |
| 25 | Orchitis (HP:0100796) | 3.97987732 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.93465091 |
| 27 | Ketosis (HP:0001946) | 3.90458126 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.90076046 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90076046 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.88489228 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.86514773 |
| 32 | Fat malabsorption (HP:0002630) | 3.84334810 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 3.82270815 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.78394645 |
| 35 | Obstructive lung disease (HP:0006536) | 3.75732816 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 3.75732816 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.73337919 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.65045302 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 3.64064467 |
| 40 | Optic neuritis (HP:0100653) | 3.64064467 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.64019315 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.62718153 |
| 43 | Hypoglycemic coma (HP:0001325) | 3.58437717 |
| 44 | Loss of speech (HP:0002371) | 3.55467740 |
| 45 | Hypoalphalipoproteinemia (HP:0003233) | 3.54124055 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.50391019 |
| 47 | Epidermoid cyst (HP:0200040) | 3.49370246 |
| 48 | Increased cerebral lipofuscin (HP:0011813) | 3.49055659 |
| 49 | Petechiae (HP:0000967) | 3.33347775 |
| 50 | Abnormality of serum amino acid levels (HP:0003112) | 3.32394802 |
| 51 | Hyperbilirubinemia (HP:0002904) | 3.24987894 |
| 52 | Gastrointestinal infarctions (HP:0005244) | 3.23077162 |
| 53 | Stomatitis (HP:0010280) | 3.21703366 |
| 54 | Hypercholesterolemia (HP:0003124) | 3.18586853 |
| 55 | Abnormality of complement system (HP:0005339) | 3.17672024 |
| 56 | Delayed CNS myelination (HP:0002188) | 3.10938169 |
| 57 | Dysostosis multiplex (HP:0000943) | 3.09551428 |
| 58 | Meningitis (HP:0001287) | 3.09147419 |
| 59 | Conjugated hyperbilirubinemia (HP:0002908) | 3.07953346 |
| 60 | Recurrent skin infections (HP:0001581) | 3.07056633 |
| 61 | Spontaneous abortion (HP:0005268) | 3.02044932 |
| 62 | Vacuolated lymphocytes (HP:0001922) | 3.02026312 |
| 63 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.01733147 |
| 64 | Steatorrhea (HP:0002570) | 3.01659254 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.99796270 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.99796270 |
| 67 | Recurrent fungal infections (HP:0002841) | 2.99285754 |
| 68 | Urticaria (HP:0001025) | 2.97221191 |
| 69 | Malnutrition (HP:0004395) | 2.95728282 |
| 70 | Lethargy (HP:0001254) | 2.88579291 |
| 71 | Increased IgE level (HP:0003212) | 2.86421007 |
| 72 | Metabolic acidosis (HP:0001942) | 2.85496497 |
| 73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.83032962 |
| 74 | Cerebral edema (HP:0002181) | 2.82780704 |
| 75 | Vasculitis (HP:0002633) | 2.81481694 |
| 76 | Purpura (HP:0000979) | 2.78270655 |
| 77 | Hepatosplenomegaly (HP:0001433) | 2.74559839 |
| 78 | Ragged-red muscle fibers (HP:0003200) | 2.72346637 |
| 79 | Nasal polyposis (HP:0100582) | 2.69321143 |
| 80 | Gingivitis (HP:0000230) | 2.65471738 |
| 81 | Ketoacidosis (HP:0001993) | 2.64103037 |
| 82 | Abnormality of the nasal mucosa (HP:0000433) | 2.62515646 |
| 83 | Hepatocellular carcinoma (HP:0001402) | 2.58952196 |
| 84 | Increased IgM level (HP:0003496) | 2.54863843 |
| 85 | Cellulitis (HP:0100658) | 2.54448993 |
| 86 | Brushfield spots (HP:0001088) | 2.48412897 |
| 87 | Gout (HP:0001997) | 2.48108677 |
| 88 | Recurrent cutaneous fungal infections (HP:0011370) | 2.47593900 |
| 89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.47593900 |
| 90 | Pulmonary infiltrates (HP:0002113) | 2.47236835 |
| 91 | Acanthocytosis (HP:0001927) | 2.47137240 |
| 92 | Late onset (HP:0003584) | 2.47104715 |
| 93 | Progressive neurologic deterioration (HP:0002344) | 2.46871541 |
| 94 | Hemoptysis (HP:0002105) | 2.46122434 |
| 95 | Keratoconjunctivitis sicca (HP:0001097) | 2.45307469 |
| 96 | Encephalitis (HP:0002383) | 2.43590229 |
| 97 | Abnormality of purine metabolism (HP:0004352) | 2.43190367 |
| 98 | Systemic lupus erythematosus (HP:0002725) | 2.42039004 |
| 99 | Opisthotonus (HP:0002179) | 2.39189647 |
| 100 | Recurrent viral infections (HP:0004429) | 2.37201141 |
| 101 | Myocardial infarction (HP:0001658) | 2.35328694 |
| 102 | Hypertensive crisis (HP:0100735) | 2.34514905 |
| 103 | Axonal loss (HP:0003447) | 2.34490197 |
| 104 | Abnormal gallbladder physiology (HP:0012438) | 2.29470211 |
| 105 | Cholecystitis (HP:0001082) | 2.29470211 |
| 106 | Colitis (HP:0002583) | 2.28933035 |
| 107 | Hepatic necrosis (HP:0002605) | 2.28650821 |
| 108 | Skin nodule (HP:0200036) | 2.26993219 |
| 109 | Anorexia (HP:0002039) | 2.26981113 |
| 110 | Abnormality of iron homeostasis (HP:0011031) | 2.26707010 |
| 111 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.25895215 |
| 112 | Gastrointestinal inflammation (HP:0004386) | 2.25110967 |
| 113 | Spastic diplegia (HP:0001264) | 2.25031210 |
| 114 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24961779 |
| 115 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24961779 |
| 116 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24961779 |
| 117 | Vomiting (HP:0002013) | 2.24731559 |
| 118 | Neonatal onset (HP:0003623) | 2.24288997 |
| 119 | Vascular calcification (HP:0004934) | 2.23948377 |
| 120 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.23915168 |
| 121 | Keratoconjunctivitis (HP:0001096) | 2.22873952 |
| 122 | Inflammation of the large intestine (HP:0002037) | 2.22435794 |
| 123 | Prolonged neonatal jaundice (HP:0006579) | 2.22200821 |
| 124 | Generalized aminoaciduria (HP:0002909) | 2.20943081 |
| 125 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.19707655 |
| 126 | Irritability (HP:0000737) | 2.17793049 |
| 127 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.17409492 |
| 128 | Premature loss of primary teeth (HP:0006323) | 2.16938125 |
| 129 | Chest pain (HP:0100749) | 2.15157342 |
| 130 | Pustule (HP:0200039) | 2.14986931 |
| 131 | Hypergammaglobulinemia (HP:0010702) | 2.14426117 |
| 132 | Increased serum ferritin (HP:0003281) | 2.13428649 |
| 133 | Hypochromic microcytic anemia (HP:0004840) | 2.13289637 |
| 134 | Disinhibition (HP:0000734) | 2.11342294 |
| 135 | Gastrointestinal stroma tumor (HP:0100723) | 2.11029240 |
| 136 | Gangrene (HP:0100758) | 2.09386769 |
| 137 | Reduced antithrombin III activity (HP:0001976) | 2.09173930 |
| 138 | Mutism (HP:0002300) | 2.08786942 |
| 139 | Episodic fever (HP:0001954) | 2.08215879 |
| 140 | Polygenic inheritance (HP:0010982) | 2.07959312 |
| 141 | Pancreatitis (HP:0001733) | 2.06794636 |
| 142 | Abnormal cartilage morphology (HP:0002763) | 2.06109361 |
| 143 | Abnormal gallbladder morphology (HP:0012437) | 2.05682191 |
| 144 | Autoimmune thrombocytopenia (HP:0001973) | 2.05645211 |
| 145 | Thrombophlebitis (HP:0004418) | 2.05488761 |
| 146 | Menorrhagia (HP:0000132) | 2.05267659 |
| 147 | Cholelithiasis (HP:0001081) | 2.04537094 |
| 148 | Mucopolysacchariduria (HP:0008155) | 2.02631647 |
| 149 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02631647 |
| 150 | Glomerulonephritis (HP:0000099) | 2.01174815 |
| 151 | Gingival bleeding (HP:0000225) | 2.00801378 |
| 152 | Interstitial pulmonary disease (HP:0006530) | 2.00032555 |
| 153 | Hypoglycemic seizures (HP:0002173) | 1.99872057 |
| 154 | Amyloidosis (HP:0011034) | 1.99077526 |
| 155 | Elevated hepatic transaminases (HP:0002910) | 1.97964468 |
| 156 | Poikilocytosis (HP:0004447) | 1.97418618 |
| 157 | Glycosuria (HP:0003076) | 1.95671602 |
| 158 | Abnormality of urine glucose concentration (HP:0011016) | 1.95671602 |
| 159 | Acute encephalopathy (HP:0006846) | 1.95479300 |
| 160 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.95061912 |
| 161 | Osteomyelitis (HP:0002754) | 1.93802509 |
| 162 | Sensorimotor neuropathy (HP:0007141) | 1.92230379 |
| 163 | Spastic paraparesis (HP:0002313) | 1.91794083 |
| 164 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91301558 |
| 165 | Skin rash (HP:0000988) | 1.91120781 |
| 166 | Cardiovascular calcification (HP:0011915) | 1.90816895 |
| 167 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90683003 |
| 168 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.88281717 |
| 169 | Skin ulcer (HP:0200042) | 1.87664124 |
| 170 | Increased muscle lipid content (HP:0009058) | 1.87301817 |
| 171 | * Lactic acidosis (HP:0003128) | 1.87049881 |
| 172 | Nausea (HP:0002018) | 1.85368081 |
| 173 | Lymphopenia (HP:0001888) | 1.85148827 |
| 174 | Megaloblastic anemia (HP:0001889) | 1.85051488 |
| 175 | Cheilitis (HP:0100825) | 1.84584765 |
| 176 | Increased serum pyruvate (HP:0003542) | 1.84044083 |
| 177 | Abnormality of glycolysis (HP:0004366) | 1.84044083 |
| 178 | Abnormality of the pleura (HP:0002103) | 1.83417760 |
| 179 | Upper motor neuron abnormality (HP:0002127) | 1.83116926 |
| 180 | Epistaxis (HP:0000421) | 1.82105179 |
| 181 | Arterial thrombosis (HP:0004420) | 1.81328062 |
| 182 | Hepatocellular necrosis (HP:0001404) | 1.80810913 |
| 183 | Agammaglobulinemia (HP:0004432) | 1.78468396 |
| 184 | Glomerulopathy (HP:0100820) | 1.77399896 |
| 185 | Recurrent pneumonia (HP:0006532) | 1.75978628 |
| 186 | Hemorrhage of the eye (HP:0011885) | 1.75804222 |
| 187 | Thoracic kyphosis (HP:0002942) | 1.75203475 |
| 188 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.73250495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.13590140 |
| 2 | ERN1 | 4.27088692 |
| 3 | NME2 | 3.80627131 |
| 4 | RIPK4 | 3.10359004 |
| 5 | SIK1 | 2.94513324 |
| 6 | FGFR4 | 2.80714173 |
| 7 | STK16 | 2.62427288 |
| 8 | KDR | 2.60296699 |
| 9 | FLT3 | 2.56785518 |
| 10 | IRAK4 | 2.50452410 |
| 11 | PRPF4B | 2.10228042 |
| 12 | TAOK3 | 2.05243210 |
| 13 | CSK | 1.97208783 |
| 14 | MAP2K3 | 1.96389816 |
| 15 | MAP3K11 | 1.86250626 |
| 16 | ABL2 | 1.83215737 |
| 17 | SMG1 | 1.82411640 |
| 18 | TYK2 | 1.80246594 |
| 19 | ACVR1B | 1.73337423 |
| 20 | SIK3 | 1.70459340 |
| 21 | MAP3K14 | 1.68137911 |
| 22 | ERBB4 | 1.67145601 |
| 23 | TNK2 | 1.67060402 |
| 24 | TBK1 | 1.63412944 |
| 25 | FGR | 1.56160776 |
| 26 | MAPK11 | 1.51746289 |
| 27 | DYRK3 | 1.48903882 |
| 28 | PIM2 | 1.48486974 |
| 29 | TESK1 | 1.43458985 |
| 30 | PKN2 | 1.39232454 |
| 31 | KIT | 1.38993676 |
| 32 | GRK6 | 1.35037616 |
| 33 | PIK3CG | 1.34356060 |
| 34 | WEE1 | 1.33675358 |
| 35 | MAP2K4 | 1.32132511 |
| 36 | MST1R | 1.31343822 |
| 37 | MAP2K6 | 1.31245405 |
| 38 | FES | 1.30363106 |
| 39 | MAP4K1 | 1.30183884 |
| 40 | MATK | 1.29622510 |
| 41 | MAP3K3 | 1.29002632 |
| 42 | IRAK2 | 1.22247311 |
| 43 | EIF2AK1 | 1.21547623 |
| 44 | EIF2AK3 | 1.19832507 |
| 45 | RPS6KA4 | 1.16719798 |
| 46 | ARAF | 1.14680409 |
| 47 | TGFBR1 | 1.14344010 |
| 48 | ADRBK2 | 1.02232656 |
| 49 | BUB1 | 1.01041122 |
| 50 | MAPK4 | 1.00716368 |
| 51 | TRIB3 | 0.97311426 |
| 52 | CSF1R | 0.96844152 |
| 53 | MUSK | 0.96491419 |
| 54 | INSRR | 0.96136805 |
| 55 | HCK | 0.95579554 |
| 56 | CDK4 | 0.95122105 |
| 57 | TGFBR2 | 0.94299351 |
| 58 | ZAP70 | 0.92229598 |
| 59 | PINK1 | 0.90347039 |
| 60 | SCYL2 | 0.89961358 |
| 61 | GRK7 | 0.89755900 |
| 62 | TAOK2 | 0.89258070 |
| 63 | CDK19 | 0.87745182 |
| 64 | PRKD2 | 0.86847653 |
| 65 | TXK | 0.84875433 |
| 66 | PAK4 | 0.84127942 |
| 67 | MAP3K10 | 0.83747948 |
| 68 | BLK | 0.81651671 |
| 69 | CDC42BPA | 0.80139231 |
| 70 | MAP3K5 | 0.79264100 |
| 71 | JAK2 | 0.78836795 |
| 72 | EPHB1 | 0.78694100 |
| 73 | VRK2 | 0.77158123 |
| 74 | PDPK1 | 0.76290754 |
| 75 | IRAK3 | 0.73647647 |
| 76 | TLK1 | 0.73177526 |
| 77 | JAK1 | 0.73022717 |
| 78 | LRRK2 | 0.72284115 |
| 79 | TIE1 | 0.71842510 |
| 80 | LCK | 0.69778409 |
| 81 | MAP3K6 | 0.69454378 |
| 82 | BRAF | 0.68546824 |
| 83 | BTK | 0.68300506 |
| 84 | TEC | 0.67418445 |
| 85 | STK10 | 0.66924835 |
| 86 | CAMK2G | 0.66847930 |
| 87 | MAPK12 | 0.65976846 |
| 88 | IRAK1 | 0.65365098 |
| 89 | MOS | 0.63390833 |
| 90 | VRK1 | 0.63303811 |
| 91 | CSNK1G3 | 0.62198314 |
| 92 | MARK2 | 0.61832977 |
| 93 | IKBKE | 0.60983016 |
| 94 | MAPK15 | 0.60058919 |
| 95 | PDK2 | 0.58870597 |
| 96 | MARK3 | 0.58763984 |
| 97 | BMX | 0.58371738 |
| 98 | CSNK1G1 | 0.57579500 |
| 99 | FRK | 0.55616309 |
| 100 | PDK1 | 0.55202227 |
| 101 | DAPK3 | 0.53173196 |
| 102 | NME1 | 0.53066097 |
| 103 | RAF1 | 0.49994155 |
| 104 | JAK3 | 0.49197751 |
| 105 | KSR2 | 0.48418879 |
| 106 | CDK8 | 0.48128038 |
| 107 | IKBKB | 0.47925326 |
| 108 | CDK6 | 0.46506843 |
| 109 | RIPK1 | 0.46329126 |
| 110 | SIK2 | 0.44475090 |
| 111 | LATS2 | 0.44351946 |
| 112 | DDR2 | 0.44289276 |
| 113 | CSNK2A2 | 0.43741904 |
| 114 | CSNK2A1 | 0.43286499 |
| 115 | RPS6KC1 | 0.43248439 |
| 116 | RPS6KL1 | 0.43248439 |
| 117 | MAPKAPK2 | 0.43008012 |
| 118 | NLK | 0.42673706 |
| 119 | NEK9 | 0.42669456 |
| 120 | MAPKAPK3 | 0.41171531 |
| 121 | GRK1 | 0.40696702 |
| 122 | LYN | 0.40556711 |
| 123 | MAP2K2 | 0.39556841 |
| 124 | CDK7 | 0.39358198 |
| 125 | PRKACG | 0.38012468 |
| 126 | MYLK | 0.37354972 |
| 127 | DAPK1 | 0.36822779 |
| 128 | ERBB2 | 0.36506087 |
| 129 | PTK6 | 0.36038056 |
| 130 | CHUK | 0.35577571 |
| 131 | BRSK2 | 0.35491453 |
| 132 | PRKCD | 0.34517089 |
| 133 | PAK1 | 0.34479218 |
| 134 | SYK | 0.34228103 |
| 135 | PIM1 | 0.34132412 |
| 136 | PRKAA2 | 0.33681082 |
| 137 | PRKG2 | 0.33571828 |
| 138 | RPS6KB2 | 0.33429362 |
| 139 | AURKA | 0.33059086 |
| 140 | TESK2 | 0.32728756 |
| 141 | BMPR2 | 0.32138747 |
| 142 | DYRK2 | 0.31594856 |
| 143 | PRKCZ | 0.31503072 |
| 144 | TAOK1 | 0.31199631 |
| 145 | MAP3K13 | 0.30823223 |
| 146 | MAP3K1 | 0.29886663 |
| 147 | EIF2AK2 | 0.29698225 |
| 148 | RPS6KA6 | 0.29536046 |
| 149 | FYN | 0.29065122 |
| 150 | MAP3K8 | 0.28049231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.35749213 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.14378682 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.96087598 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.88476307 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86708545 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.74116636 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.68011084 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.66923852 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.66629506 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.66624927 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.65325502 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.58127307 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56030661 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.52531251 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.50380281 |
| 16 | Asthma_Homo sapiens_hsa05310 | 2.44348406 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.42516173 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35657993 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.34078418 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.24754394 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20867392 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 2.16446816 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.15817917 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 2.10359860 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.02353025 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97422251 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.97080212 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.96509278 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.96032252 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.95909866 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.92846563 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92773176 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88960101 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86181181 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.85886521 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85722670 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.85150716 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.81501242 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.78473813 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78122422 |
| 41 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.77868787 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77073219 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.75584547 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75086228 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 1.73248519 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.70729554 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70385885 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.69626415 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.68583583 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67329912 |
| 51 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66121230 |
| 52 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.65103616 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.64910039 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 1.63968877 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.63541359 |
| 56 | Pertussis_Homo sapiens_hsa05133 | 1.62945283 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.60200104 |
| 58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59350602 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 1.58525193 |
| 60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57407658 |
| 61 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55523812 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.54507407 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52635991 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51961998 |
| 65 | Malaria_Homo sapiens_hsa05144 | 1.49730544 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.49201364 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.47620655 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47273201 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44366107 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 1.41132780 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40257970 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.37510870 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37362043 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.35920228 |
| 75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34676554 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34328350 |
| 77 | Measles_Homo sapiens_hsa05162 | 1.33137920 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29936573 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.29749977 |
| 80 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26824162 |
| 81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25249525 |
| 82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.24763123 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23168372 |
| 84 | Shigellosis_Homo sapiens_hsa05131 | 1.23008115 |
| 85 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22995749 |
| 86 | Bile secretion_Homo sapiens_hsa04976 | 1.22562794 |
| 87 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.22327934 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21843753 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.15748575 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14158819 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.12423812 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 1.11843898 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09075564 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08786145 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 1.08207762 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04001829 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03884715 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03864159 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.98074373 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.97925394 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.95052627 |
| 102 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.94239003 |
| 103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93766069 |
| 104 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93362912 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92880821 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92592971 |
| 107 | Hepatitis B_Homo sapiens_hsa05161 | 0.89371276 |
| 108 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88755784 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83765564 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82223041 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78502385 |
| 112 | Ribosome_Homo sapiens_hsa03010 | 0.75125528 |
| 113 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73973405 |
| 114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68321164 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67209897 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64461982 |
| 117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63333698 |
| 118 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.62792955 |
| 119 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62290274 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61251318 |
| 121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60529051 |
| 122 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60490264 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.55798256 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55540253 |
| 125 | Base excision repair_Homo sapiens_hsa03410 | 0.51670611 |
| 126 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51652446 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51650382 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50595019 |
| 129 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50449865 |
| 130 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49700163 |
| 131 | Proteasome_Homo sapiens_hsa03050 | 0.48485015 |
| 132 | Lysine degradation_Homo sapiens_hsa00310 | 0.48482503 |
| 133 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48279765 |
| 134 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42182609 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41701899 |
| 136 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39028254 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37822641 |
| 138 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35921596 |
| 139 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34005580 |
| 140 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33589099 |
| 141 | Amoebiasis_Homo sapiens_hsa05146 | 0.33415464 |
| 142 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32166605 |
| 143 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31966524 |
| 144 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31500079 |
| 145 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30900290 |
| 146 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30299656 |
| 147 | RNA polymerase_Homo sapiens_hsa03020 | 0.27524313 |
| 148 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24176343 |
| 149 | Prion diseases_Homo sapiens_hsa05020 | 0.22836182 |
| 150 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21771492 |
| 151 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.21703734 |
| 152 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.19226421 |
| 153 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17703696 |
| 154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17631903 |
| 155 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.17568435 |
| 156 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.17347695 |
| 157 | Protein export_Homo sapiens_hsa03060 | 0.15981474 |
| 158 | Parkinsons disease_Homo sapiens_hsa05012 | 0.15870975 |
| 159 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15561491 |
| 160 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.11316244 |
| 161 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.11272759 |
| 162 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.10665697 |
| 163 | DNA replication_Homo sapiens_hsa03030 | 0.10516448 |
| 164 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.09847389 |
| 165 | Purine metabolism_Homo sapiens_hsa00230 | 0.09748478 |
| 166 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.02271214 |
| 167 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.01752026 |
| 168 | Insulin resistance_Homo sapiens_hsa04931 | 0.00971423 |
| 169 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.0935504 |
| 170 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0741709 |
| 171 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0636348 |
| 172 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0541475 |
| 173 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0457797 |
| 174 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0349224 |
| 175 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0145981 |

